Legal identity
Hikma Pharmaceuticals PLC
hikma.com
Hikma is a leading global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.
- Industry
- Pharmaceuticals
- Headquarters
- London, England, United Kingdom
- Security grade
- B (88/100)
OrgIntel 360 snapshot
Identity, industry, location, and adjacent module links in one public dossier.
Evidence-bound gaps
Missing leadership, relationships, or scores stay missing — never filled with zeros.
Canonical profile
Each entity links to its geographic company URL when that path exists.
Secured data is stored behind the vault
Only authorised users can get access. The secured data is stored behind the vault — please sign in to access more data.
Related organisations
Accredo Specialty Ph...
accredo.com
Pets at Home Ltd
petsathome.com
Archer Daniels Midla...
adm.com
Exceptional Care Any...
advocatehealth.com
Veradigm LLC
allscripts.com
Ambulance Victoria
ambulance.vic.gov.au
Quick answer
What is known about Hikma Pharmaceuticals PLC?
Hikma Pharmaceuticals PLC (hikma.com) is an indexed organisation on OrgIntel360. Public records place it in Pharmaceuticals. Headquarters signals point to London, England, United Kingdom.
Hikma is a leading global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.
This page synthesises the OrgIntel 360 preview. Open the full organization profile for the canonical company record, or compare Corporate Intelligence for structure-focused context.
Frequently asked questions
Understanding the profile
Hikma Pharmaceuticals PLC is classified under Pharmaceuticals (Healthcare).
Hikma is a leading global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.
Public location fields place operations in London, England, United Kingdom.
See organisations in the same geography via Geo-Intelligence.
Leadership details are not listed in the current public record for Hikma Pharmaceuticals PLC.
No verified relationship is present in the current dataset. Absence of names is not evidence that the organisation has no officers or affiliates.
Interpreting signals
The strongest verified public signals for Hikma Pharmaceuticals PLC are industry Pharmaceuticals, location London, England, United Kingdom, security letter grade B (88/100), and founded 2025.
The security grade is one OrgIntel dimension, not a substitute for vendor, reputation, or threat evidence.
For counterparties evaluating Hikma Pharmaceuticals PLC, the public dossier is a first-pass identity and context check in Pharmaceuticals based in London, England, United Kingdom.
The available letter grade B (88/100) is a stakeholder-relevant outside-in signal, not a credit, legal, or financial rating.
Use the canonical organization profile when you need the full public assessment record.
Considerations for Hikma Pharmaceuticals PLC split across identity completeness, Pharmaceuticals operating context, and any scored cyber signal.
Cyber is present as letter grade B (88/100). Vendor dependencies, reputation themes, and threat actors are not inferred on this page unless those modules publish verified evidence.
Continue in Risk Intelligence for exposure-focused follow-up.
What to do next
For Hikma Pharmaceuticals PLC, confirm domain-to-entity mapping, and any names used in contracts.
The public preview still lacks leadership; those should be collected from the organisation or a full audit rather than filled with assumptions.
The most relevant next step for Hikma Pharmaceuticals PLC is to open the full organization profile and decide whether Corporate, Risk, or Vendor intelligence answers the remaining diligence questions.
The existing grade is enough for triage; authenticated monitoring is the follow-on if this organisation will sit in a portfolio.